Antagonizing CXCR4 accelerates CD34+ cell mobilization

被引：1
|
作者：
Devine, SM [1 ]
机构：
[1] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA
来源：
BLOOD | 2005年 / 106卷 / 12期
关键词：
D O I：
10.1182/blood-2005-09-3683
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A novel bicyclam CXCR4 antagonist, AMD3100, appears capable of mobilizing a fully functional hematopoietic allograft within just 6 hours following a single injection.
引用
收藏
页码：3685 / 3686
页数：2
相关论文
共 50 条
  • [21] CXCR4 expression in CD34+ cells and unit predominance after double umbilical cord blood transplantation
    Ramirez, P.
    Wagner, J. E.
    DeFor, T. E.
    Eide, C. R.
    Miller, J. S.
    Weisdorf, D. J.
    Brunstein, C. G.
    LEUKEMIA, 2013, 27 (05) : 1181 - 1183
  • [22] CXCR4 expression in CD34+ cells and unit predominance after double umbilical cord blood transplantation
    P Ramirez
    J E Wagner
    T E DeFor
    C R Eide
    J S Miller
    D J Weisdorf
    C G Brunstein
    Leukemia, 2013, 27 : 1181 - 1183
  • [23] The High-Affinity CXCR4 Antagonist BKT140 Is Safe and Induces a Robust Mobilization of Human CD34+ Cells in Patients with Multiple Myeloma
    Peled, Amnon
    Abraham, Michal
    Avivi, Irit
    Rowe, Jacob M.
    Beider, Katia
    Wald, Hanna
    Tiomkin, Lena
    Ribakovsky, Lena
    Riback, Yossi
    Ramati, Yaron
    Aviel, Sigal
    Galun, Eithan
    Shaw, Howard Laurence
    Eizenberg, Orly
    Hardan, Izhar
    Shimoni, Avichai
    Nagler, Arnon
    CLINICAL CANCER RESEARCH, 2014, 20 (02) : 469 - 479
  • [24] CXCR4 AND MOBILIZATION OF HEMATOPOIETIC PRECURSORS
    Rettig, Michael P.
    Ramirez, Pablo
    Nervi, Bruno
    DiPersio, John F.
    CHEMOKINES, PT A, 2009, 460 : 57 - +
  • [25] A novel CXCR4 antagonist for hematopoietic stem cell mobilization
    Fricker, Simon P.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2008, 17 (11) : 1749 - 1760
  • [26] Spontaneous migration of CD34+ progenitor cells beneath marrow stromal cells (pseudoemperipolesis) requires VLA-4 integins and the CXCR4 chemokine receptor and differentially affects cell cycle progression in CD34+ progenitor cells or CD34+ myeloid leukemia cells.
    Burger, JA
    Zou, BR
    Dwenger, A
    Behringer, D
    BLOOD, 2000, 96 (11) : 688A - 688A
  • [27] CXCR-4 expression on bone marrow CD34+ cells prior to mobilization can predict mobilization adequacy in patients with hematologic malignancies
    Dabusti, M
    Lanza, F
    Campioni, D
    Castagnari, B
    Tieghi, A
    Moretti, S
    Punturieri, M
    De Angeli, C
    Spanedda, R
    Ferrazzi, E
    Castoldi, G
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2003, 12 (04): : 425 - 434
  • [28] Expression of CXCR4, the receptor for SDF-1/PBSF, on adult and fetal human CD34+ cells.
    Aiuti, A
    Cipponi, A
    Tavian, M
    Arcelloni, C
    Zappone, E
    Ficara, F
    Paroni, R
    Hoxie, J
    Peault, B
    Bordignon, C
    BLOOD, 1997, 90 (10) : 1142 - 1142
  • [29] Spontaneous and rapid reexpression of functional CXCR4 by human steady-state peripheral blood CD34+ cells
    Hirayama, F
    Yamaguchi, M
    Yano, M
    Yasui, K
    Horie, Y
    Matsumoto, K
    Nagao, N
    Ikebuchi, K
    Azuma, H
    Ikeda, H
    Tani, Y
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2003, 78 (01) : 48 - 55
  • [30] PRIMARY MYELOFIBROSIS CD34+ CELLS SHOW DIFFERENT CXCR4 CHEMOKINE RECEPTOR PROFILES AT SITES OF DISEASE ACTIVITY
    Massa, M.
    Campanelli, R.
    Rosti, V.
    Bonetti, E.
    Moretti, E.
    Villani, L.
    Lo Po, S.
    Barosi, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 356 - 356
12345